Yong Sang Hong

7PUBLICATIONS
60CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 21, 2026
Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

|Mar 23, 2026
The Randomized Phase II ARC-9 Study of Etrumadenant-Based Therapy versus Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer.

Michael Cecchini, Sae-Won Han, Soohyeon Lee

|Jan 03, 2026
Clinical utility of longitudinal circulating tumor DNA analysis in metastatic colorectal cancer patients receiving palliative chemotherapy.

Chung Ryul Oh, Ji-Young Lee, Jeong Eun Kim

|Sep 07, 2022
Clinical outcomes of curative surgical resection of peritoneal metastasis in patients with colorectal cancer: A long-term follow-up study.

Kyunghye Bang, Jeong Eun Kim, Tae Won Kim

|Jun 30, 2022
Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07.

Seung Tae Kim, Sun Young Kim, Jeeyun Lee

Pageof 2

Frequent Collaborators

3 joint publications

Seok-Byung Lim

3 joint publications

Sae-Won Han

2 joint publications

Hyun-Ki Kim

2 joint publications

Jeong-Sik Byeon